Antidepressants: Can't live with them, can't live without them

CNS Spectrums

Volumn 15, Issue 3, 2010, Pages 146-147

  Nierenberg, Andrew A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ANXIETY DISORDER; CLINICAL TRIAL; EDITORIAL; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL STRESS; PRIORITY JOURNAL; RATING SCALE; RECURRENT DISEASE; SCORING SYSTEM; META ANALYSIS; METHODOLOGY; PSYCHOLOGICAL ASPECT;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; HUMANS; META-ANALYSIS AS TOPIC; RESEARCH DESIGN;

EID: 77952316915     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900027395     Document Type: Editorial

References (13)

1. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient'level meta-analysis. JAMA. 2010;303:47-53.
2. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med. 2008;5:260-268.
3. Turner EH, Matthews AM, Lindardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.
4. Targum SD, Pollack MH, Fava M. Redefining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008;14:2-9.
5. Kessler RC, Berglund P, Demler O, et al. The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
6. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
7. Murphy JM, Burke JD, Jr., Monson RR, et al. Mortality associated with depression: a forty-year perspective from the Stirling County Study. Soc Psychiatry Psychiatr Epidemiol. 2008;43:594-601.
8. Hanssen TA, Nordrehaug JE, Eide GE, Bjelland I, Rokne B. Anxiety and depression after acute myocardial infarction: an 18-month follow-up study with repeated measures and comparison with a reference population. Eur J Cardiovasc Prev Rehabil. 2009;16:651-659.
9. Huffman JC, Smith FA, Blais MA, Taylor AM, Januzzi JL, Fricchione GL. Pre-existing major depression predicts in-hospital cardiac complications after acute myocardial infarction. Psychosomatics. 2008;49:309-316.
10. Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med. 2009;1-8.
11. Zimmerman M, Chelminski I, Posternak MA. Generalizability of antidepressant efficacy trials: Differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am J Psychiatry. 2005;162:1370-1372.
12. Kobak KA, Kane JM, Thase ME, Nierenberg AA. Why do clinical trials fail? The problem of measurement error in clinical trials: Time to test new paradigms? J Clin Psychopharmacol. 2007;27:1-5.
13. Gonzalez HM, Vega WA, Williams DR, Tarraf W, West BT, Neighbors HW. Depression care in the United States: too little for too few. Arch Gen Psychiatry. 2010;67:37-46.